SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Jonsson Erik G.) ;pers:(Jónsson Olafur G.)"

Sökning: WFRF:(Jonsson Erik G.) > Jónsson Olafur G.

  • Resultat 1-10 av 24
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Nordlund, Jessica, et al. (författare)
  • Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia
  • 2013
  • Ingår i: Genome Biology. - : Springer Science and Business Media LLC. - 1465-6906 .- 1474-760X. ; 14:9, s. r105-
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND:Although aberrant DNA methylation has been observed previously in acute lymphoblastic leukemia (ALL), the patterns of differential methylation have not been comprehensively determined in all subtypes of ALL on a genome-wide scale. The relationship between DNA methylation, cytogenetic background, drug resistance and relapse in ALL is poorly understood.RESULTS:We surveyed the DNA methylation levels of 435,941 CpG sites in samples from 764 children at diagnosis of ALL and from 27 children at relapse. This survey uncovered four characteristic methylation signatures. First, compared with control blood cells, the methylomes of ALL cells shared 9,406 predominantly hypermethylated CpG sites, independent of cytogenetic background. Second, each cytogenetic subtype of ALL displayed a unique set of hyper- and hypomethylated CpG sites. The CpG sites that constituted these two signatures differed in their functional genomic enrichment to regions with marks of active or repressed chromatin. Third, we identified subtype-specific differential methylation in promoter and enhancer regions that were strongly correlated with gene expression. Fourth, a set of 6,612 CpG sites was predominantly hypermethylated in ALL cells at relapse, compared with matched samples at diagnosis. Analysis of relapse-free survival identified CpG sites with subtype-specific differential methylation that divided the patients into different risk groups, depending on their methylation status.CONCLUSIONS:Our results suggest an important biological role for DNA methylation in the differences between ALL subtypes and in their clinical outcome after treatment.
  •  
3.
  •  
4.
  •  
5.
  • Frost, Britt-Marie, et al. (författare)
  • Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia
  • 2004
  • Ingår i: Blood. - Washington : American society of hematology. - 0006-4971 .- 1528-0020. ; 104:8, s. 2452-2457
  • Tidskriftsartikel (refereegranskat)abstract
    • The t(12;21) (p13;q22) translocation resulting in ETV6/RUNX1 (previously named TEL/AML1) gene fusion is present in about 25% of children with precursor B-lineage acute lymphoblastic leukemia (B-ALL). We successfully tested 275 precursor BALL samples from children aged 1 to 17 years to determine the relation between t(12;21) and in vitro cellular drug resistance, measured by the fluorometric microculture cytotoxicity assay (FMCA). Samples from 83 patients (30%) were positive for t(12;21). The ETV6/RUNX1(+) samples were significantly more sensitive than ETV6/RUNX1(-) samples to doxorubicin, etoposide, amsacrine, and dexamethasone, whereas the opposite was true for cytarabine. After matching for unevenly distributed patient characteristics, that is, excluding patients with high hyperdiploidy (> 51 chromosomes), t(g;22), t(1;19), or 11q23 rearrangement, the ETV6/RUNX1(+) samples remained significantly more sensitive to doxorubicin (P = .001) and etoposide (P = .001). For the other drugs tested (amsacrine, cytarabine, dexamethasone, prednisolone, vincristine, 6-thioguanine, and 4-hydroper-oxy-cyclophosphamide), no significant difference in cellular drug sensitivity was found. In conclusion, we found that the presence of the t(12;21) translocation in childhood precursor B-ALL is associated with a high tumor cell sensitivity to doxorubicin and etoposide. High throughput techniques should now be used to elucidate the cellular mechanisms by which ETV6/RUNX1 gene fusion is linked to increased sensitivity to these drugs.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Karlsson, Lena, 1964, et al. (författare)
  • Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia
  • 2017
  • Ingår i: British Journal of Haematology. - : WILEY. - 0007-1048 .- 1365-2141. ; 178:4, s. 592-602
  • Tidskriftsartikel (refereegranskat)abstract
    • Given that 30-40% of children with acute myeloid leukaemia (AML) relapse after primary therapy it is important to define prognostic factors and identify optimal therapy. From 1993 to 2012, 543 children from the Nordic countries were treated according to two consecutive protocols: 208 children relapsed. The influence of disease characteristics, first line treatment, relapse therapy and duration of first remission on outcome was analysed. Second complete remission (CR2) was achieved in 146 (70%) patients. Estimated 5-year overall survival (OS5y) was 39 +/- 4% for the whole group and 43 +/- 4% for the 190 patients given re-induction therapy, of whom 76% received regimens that included fludarabine, cytarabine (FLA) +/- anthracyclines, 18% received Nordic Society for Paediatric Haematology and Oncology (NOPHO) upfront blocks and 5% received other regimens. Late relapse >= 1 year from diagnosis, no allogeneic stem cell transplantation (SCT) in first remission and core binding factor AML were independent favourable prognostic factors for survival. For the 128 children (124 in CR2) that received SCT as consolidation therapy after relapse, OS5y was 61 +/- 5%. Four of 19 children (21%) survived without receiving SCT as part of relapse therapy. Our data show that intensive re-induction followed by SCT can give cure rates of 40% in children with relapsed AML.
  •  
10.
  • Krali, Olga, et al. (författare)
  • Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia
  • 2023
  • Ingår i: npj Precision Oncology. - : Springer Nature. - 2397-768X. ; 7:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Genomic analyses have redefined the molecular subgrouping of pediatric acute lymphoblastic leukemia (ALL). Molecular subgroups guide risk-stratification and targeted therapies, but outcomes of recently identified subtypes are often unclear, owing to limited cases with comprehensive profiling and cross-protocol studies. We developed a machine learning tool (ALLIUM) for the molecular subclassification of ALL in retrospective cohorts as well as for up-front diagnostics. ALLIUM uses DNA methylation and gene expression data from 1131 Nordic ALL patients to predict 17 ALL subtypes with high accuracy. ALLIUM was used to revise and verify the molecular subtype of 281 B-cell precursor ALL (BCP-ALL) cases with previously undefined molecular phenotype, resulting in a single revised subtype for 81.5% of these cases. Our study shows the power of combining DNA methylation and gene expression data for resolving ALL subtypes and provides a comprehensive population-based retrospective cohort study of molecular subtype frequencies in the Nordic countries.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 24
Typ av publikation
tidskriftsartikel (21)
konferensbidrag (3)
Typ av innehåll
refereegranskat (22)
övrigt vetenskapligt/konstnärligt (2)
Författare/redaktör
Jonsson, Olafur G. (24)
Forestier, Erik (24)
Hasle, Henrik (15)
Lausen, Birgitte (15)
Jahnukainen, Kirsi (15)
Zeller, Bernward (14)
visa fler...
Palle, Josefine (13)
Abrahamsson, Jonas, ... (9)
Abrahamsson, Jonas (9)
Heldrup, Jesper (9)
Ha, Shau-Yin (8)
Heyman, Mats (7)
Schmiegelow, Kjeld (7)
Larsson, Rolf (4)
Nordlund, Jessica (4)
Palle, Josefine, 196 ... (3)
Harila-Saari, Arja (2)
Cavelier, Lucia (2)
Syvänen, Ann-Christi ... (2)
Arvidson, Johan, 195 ... (2)
Gustafsson, Mats G. (2)
Rosenquist, Richard (2)
Dahlberg, Johan (2)
Kanduri, Meena, 1974 (2)
Palmqvist, Lars, 196 ... (2)
Vaitkeviciene, Goda (2)
Marquart, Hanne Vibe ... (2)
Harila, Arja (1)
Gustafsson, Mats (1)
Gustafsson, Göran (1)
Lilljebjörn, Henrik (1)
Fioretos, Thoas (1)
Asdahl, Peter H. (1)
De Moerloose, Barbar ... (1)
Eloranta, Maija-Leen ... (1)
Bottai, Matteo (1)
Rönnblom, Lars (1)
Pastinen, Tomi (1)
Nygren, Peter (1)
Övernäs, Elin (1)
Lundmark, Anders (1)
Montgomery, Scott, 1 ... (1)
Lahteenmaki, Paivi (1)
Wahlberg, Per (1)
Busche, Stephan (1)
Fogelstrand, Linda, ... (1)
Syvänen, Ann-Christi ... (1)
Heyman, Mats M. (1)
Myrberg, Ida Hed (1)
Taskinen, Mervi (1)
visa färre...
Lärosäte
Umeå universitet (20)
Uppsala universitet (19)
Karolinska Institutet (13)
Göteborgs universitet (9)
Lunds universitet (7)
Örebro universitet (1)
Språk
Engelska (24)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (23)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy